Precigen (PGEN) FCF Margin (2012 - 2026)

Precigen (PGEN) reported FCF Margin of 189.6% for Q1 2026, up 107416.0% year-over-year from N/an in Q1 2025, and up 62.7% quarter-over-quarter from 508.35% in Q4 2025.

Precigen (PGEN) FCF Margin (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of FCF Margin data on file, last reported at 189.6% in Q1 2026.

  • FCF Margin for Q1 2026 came in at 189.6%, up 107416.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 413.57% (up 136939.0% YoY), and the FY2025 annual result was 909.18%, up 104641.0% from the prior year.
  • FCF Margin advanced to 189.6% in Q1 2026 per PGEN's latest filing, from 508.35% in the prior quarter.
  • Over five years, FCF Margin peaked at 140.61% in Q4 2022 and troughed at 1724400.0% in Q3 2023.
  • A 5-year average of 113345.09% and a median of 1223.74% in 2022 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2023 and 2024: FCF Margin slumped 172321629 bps in 2023, then surged 172250474 bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 140.61% in 2022, then slumped by 1017 bps to 1289.98% in 2023, then gained by 14 bps to 1112.23% in 2024, then surged by 54 bps to 508.35% in 2025, then jumped by 63 bps to 189.6% in 2026.
  • Business Quant data shows PGEN's FCF Margin at 189.6% in Q1 2026, 508.35% in Q4 2025, and 58655.88% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 43.35%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn -189.60%

Historic Data

Download Data
DateValue
Mar 31, 2026 -189.60%
Dec 31, 2025 -508.35%
Jun 30, 2025 -58,655.88%
Mar 31, 2025 -1,263.76%
Dec 31, 2024 -1,112.23%
Sep 30, 2024 -1,895.26%
Jun 30, 2024 -4,111.74%
Mar 31, 2024 -11,738.41%
Dec 31, 2023 -1,289.98%
Sep 30, 2023 -1,724,400.00%
Jun 30, 2023 -898.08%
Mar 31, 2023 -5,722.84%
Dec 31, 2022 140.61%
Sep 30, 2022 -1,183.71%
Jun 30, 2022 -346.93%
Mar 31, 2022 -345.26%
Dec 31, 2021 149.94%
Sep 30, 2021 -507.92%
Jun 30, 2021 -182.52%
Mar 31, 2021 -70.98%